Literature DB >> 16269653

Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.

Xun Ai1, Jerry W Curran, Thomas R Shannon, Donald M Bers, Steven M Pogwizd.   

Abstract

Abnormal release of Ca from sarcoplasmic reticulum (SR) via the cardiac ryanodine receptor (RyR2) may contribute to contractile dysfunction and arrhythmogenesis in heart failure (HF). We previously demonstrated decreased Ca transient amplitude and SR Ca load associated with increased Na/Ca exchanger expression and enhanced diastolic SR Ca leak in an arrhythmogenic rabbit model of nonischemic HF. Here we assessed expression and phosphorylation status of key Ca handling proteins and measured SR Ca leak in control and HF rabbit myocytes. With HF, expression of RyR2 and FK-506 binding protein 12.6 (FKBP12.6) were reduced, whereas inositol trisphosphate receptor (type 2) and Ca/calmodulin-dependent protein kinase II (CaMKII) expression were increased 50% to 100%. The RyR2 complex included more CaMKII (which was more activated) but less calmodulin, FKBP12.6, and phosphatases 1 and 2A. The RyR2 was more highly phosphorylated by both protein kinase A (PKA) and CaMKII. Total phospholamban phosphorylation was unaltered, although it was reduced at the PKA site and increased at the CaMKII site. SR Ca leak in intact HF myocytes (which is higher than in control) was reduced by inhibition of CaMKII but was unaltered by PKA inhibition. CaMKII inhibition also increased SR Ca content in HF myocytes. Our results suggest that CaMKII-dependent phosphorylation of RyR2 is involved in enhanced SR diastolic Ca leak and reduced SR Ca load in HF, and may thus contribute to arrhythmias and contractile dysfunction in HF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269653     DOI: 10.1161/01.RES.0000194329.41863.89

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  319 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

Review 2.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

3.  The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function.

Authors:  Andriy E Belevych; Dmitry Terentyev; Radmila Terentyeva; Yoshinori Nishijima; Arun Sridhar; Robert L Hamlin; Cynthia A Carnes; Sandor Györke
Journal:  Cardiovasc Res       Date:  2011-01-27       Impact factor: 10.787

4.  Dynamics of calcium sparks and calcium leak in the heart.

Authors:  George S B Williams; Aristide C Chikando; Hoang-Trong M Tuan; Eric A Sobie; W J Lederer; M Saleet Jafri
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

Review 5.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

6.  A brighter side of ROS revealed by selective activation of beta-adrenergic receptor subtypes.

Authors:  Nora Biary; Fadi G Akar
Journal:  J Physiol       Date:  2010-08-15       Impact factor: 5.182

7.  How does CaMKIIdelta phosphorylation of the cardiac ryanodine receptor contribute to inotropy?

Authors:  David A Eisner; Christopher H George; Godfrey L Smith; Andrew W Trafford; Luigi A Venetucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

8.  Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.

Authors:  Takeshi Aiba; Geoffrey G Hesketh; Andreas S Barth; Ting Liu; Samantapudi Daya; Khalid Chakir; Veronica Lea Dimaano; Theodore P Abraham; Brian O'Rourke; Fadi G Akar; David A Kass; Gordon F Tomaselli
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

Review 9.  New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).

Authors:  Adam G Rokita; Mark E Anderson
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

10.  Na(+) channel I-II loop mediates parallel genetic and phosphorylation-dependent gating changes.

Authors:  Donald M Bers; Anthony W Herren
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.